Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
The New Zealand Medical Journal
|
June 14, 2008
Medical image. The pink lady
Ricardo Jurawan, Malcolm Arnold
Cardiovascular Research
|
June 10, 2009
Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes
Ying Li, Yanwen Li, Qingping Feng, et al.
Circulation
|
January 4, 2008
Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease
Marcello Tonelli, Frank Sacks, Malcolm Arnold, et al.
The New Zealand Medical Journal
|
August 11, 2020
Challenges for the future: the gastroenterology specialist workforce in New Zealand
Rosemary Stamm, Kristina Aluzaite, Malcolm Arnold, et al.
The New Zealand Medical Journal
|
December 17, 2020
Why does Pharmac neglect inflammatory bowel disease?
Andrew McCombie, Malcolm Arnold, Marian O'Connor, et al.
The Canadian Journal of Cardiology
|
May 28, 2008
Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes?
J Malcolm Arnold, David H Fitchett, Jonathan G Howlett, et al.
American Journal of Hypertension
|
August 3, 2016
Coffee-Antihypertensive Drug Interaction: A Hemodynamic and Pharmacokinetic Study With Felodipine
David G Bailey, George K Dresser, Brad L Urquhart, et al.
Pharmacology Research & Perspectives
|
October 4, 2017
Coffee inhibition of CYP3A4 in vitro was not translated to a grapefruit-like pharmacokinetic interaction clinically
George K Dresser, Brad L Urquhart, Julianne Proniuk, et al.
Current Opinion in Cardiology
|
December 24, 2008
Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design
Anthony S Tang, George A Wells, Malcolm Arnold, et al.
Diabetes
|
September 14, 2011
Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes
Ying Li, Jian Ma, Huaqing Zhu, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
The New Zealand Medical Journal
|
June 14, 2008
Medical image. The pink lady
Ricardo Jurawan, Malcolm Arnold
Cardiovascular Research
|
June 10, 2009
Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes
Ying Li, Yanwen Li, Qingping Feng, et al.
Circulation
|
January 4, 2008
Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease
Marcello Tonelli, Frank Sacks, Malcolm Arnold, et al.
The New Zealand Medical Journal
|
August 11, 2020
Challenges for the future: the gastroenterology specialist workforce in New Zealand
Rosemary Stamm, Kristina Aluzaite, Malcolm Arnold, et al.
The New Zealand Medical Journal
|
December 17, 2020
Why does Pharmac neglect inflammatory bowel disease?
Andrew McCombie, Malcolm Arnold, Marian O'Connor, et al.
The Canadian Journal of Cardiology
|
May 28, 2008
Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes?
J Malcolm Arnold, David H Fitchett, Jonathan G Howlett, et al.
American Journal of Hypertension
|
August 3, 2016
Coffee-Antihypertensive Drug Interaction: A Hemodynamic and Pharmacokinetic Study With Felodipine
David G Bailey, George K Dresser, Brad L Urquhart, et al.
Pharmacology Research & Perspectives
|
October 4, 2017
Coffee inhibition of CYP3A4 in vitro was not translated to a grapefruit-like pharmacokinetic interaction clinically
George K Dresser, Brad L Urquhart, Julianne Proniuk, et al.
Current Opinion in Cardiology
|
December 24, 2008
Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design
Anthony S Tang, George A Wells, Malcolm Arnold, et al.
Diabetes
|
September 14, 2011
Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes
Ying Li, Jian Ma, Huaqing Zhu, et al.
Page
of 3